Her kan du lese mer om den forskningen som vi og våre søster-stiftelser i Sverige og Finland har vært med på å finansiere siden starten i 2008. Vi støtter både forskning innenfor diabetes typ 1 og diabetes type 2.

Diabetes Wellness søker aktivt etter prosjekter som antas å ha de beste forutsetninger for å utvikle forbedrede behandlingsmåter eller å komme nærmere en endelig kur for diabetes.

Vår rådgivende komité vurderer mottatte søknader og gir sin anbefaling til styret, som fatter den endelige beslutningen.

Siden starten har Diabetes Wellness Sverige finansiert forskning for nærmere 100 millioner kroner, takket være de gavmilde menneskene som har valgt å støtte vårt arbeide.

Diabetes Wellness Norge er fortsatt relativt ung, og vi arbeider med å etablere en stabil base med støttespillere som kan hjelpe oss å finansiere forskning, både i Norge og utlandet.

Inntil videre kan du lese om noen av de prosjektene som vår svenske søsterorganisasjon har støttet.


Vil du være med og støtte forskningen?

Gjennom å støtte Diabetes Wellness Norge hjelper du oss i kampen mot diabetes. Din støtte bidrar ikke bare til å finansiere forskning på diabetes, men også til å informere allmennheten om sykdommen og dens mange farlige komplikasjoner.

Du hjelper oss ved å betale inn et valgfritt beløp til vår bankkonto 9046 12 86215. Husk at alle beløp er til nytte, og at ingen gave er for liten.

2025

  • Norge
  • Norden

Dr Bente Berg Johansson, University of Bergen

200 000 NOK

Underreporting of Syndromic Monogenic Diabetes in Norwegian Diabetes Registries: A call for comprehensive screening.

Professor Simon N Dankel, University of Bergen

200 000 NOK

Remission of type 2 diabetes and saliva and gut microbiomes following two 15-month diet interventions: a randomised controlled trial.

Dr Anne-Marie Aas, Oslo University Hospital

200 000 NOK

DiaMester: e-health lifestyle program for improved self-management and remission of type 2 diabetes – a pilot RCT.

Ms Kamilla La Haganes, Norwegian University of Science and Technology

200 000 NOK

Effective and feasible lifestyle interventions for people with overweight/obesity.

Dr Hanna Dis Margeirsdottir, Oslo University Hospital

200 000 NOK

Atherosclerosis in Childhood Diabetes (ACD): 15-year follow-up study.

2024

  • Norge
  • Norden

Professor Nils Wierup, Lund University

50 000 NOK

Studies of T2D disease mechanisms in human islets.

Dr Ola Hansson, Lund University

2 000 000 SEK

Precision medicine for increased physical fitness and muscle health in the treatment of diabetes.

Ass Professor Gustaf Christoffersson, Uppsala University

2 000 000 SEK

Discovery of islet-resident catecholamine-producing B cells as promising potent regulatory Immune cells in type 1 diabetes.

Dr Emma Ahlqvist, Lund University

1 999 800 SEK

Using genomic analysis to elucidate disease mechanisms for type 2 diabetes and its comorbidities.

Dr Jon Edqvist, University of Gothenburg

200 000 SEK

Early social marginalization in young and middle-aged individuals with type 1 and type 2 diabetes: Excess risk and machine learning based prediction.

Dr Tina Gorsek Sparovec, Karolinska Institute

200 000 SEK

Transcriptomic landscape of skeletal muscle in polycystic ovary syndrome.

Dr Robin Lindsay, Uppsala University

180 000 SEK

Linking T cell behaviour and gene expression profiles to determine tolerance mechanisms to halt progression of type 1 diabetes.

Dr Fariborz Parandeh, Lund University

200 000 SEK

Increased and cell surface miss-targetting of mitochondrial VDAC1 causes mtDNA leakage leading to autoimmune response and causing beta-cell demise in type 1 diabetes.

Dr Anna-Maria Lampousi, Karolinska Institute

200 000 SEK

Breastfeeding and risk of childhood type 1 diabetes: mechanisms and effect modifiers.

Professor Kirsi Laitinen, University of Turku

20 000 EUR

Impact of gestational diabetes mellitus on child gut microbiota and neurocognitive development.

Dr Sami Jalil, University of Helsinki

20 000 EUR

Genome Editing in Human Stem Cell-Derived Islets: A Novel Strategy for Treating Monogenic Diabetes.

Dr Inna Starskaia, University of Turku

20 000 EUR

In-depth analysis of immune response to identify changes associated with progression and endotypes of type 1 diabetes.

Dr Kedar Batkulwar, University of Turku

20 000 EUR

Importance of a novel miRNA in the development and early prediction of type 1 diabetes.

Dr Krishna Adeshara, University of Helsinki

10 000 EUR

Unraveling the genetic and epigenetic landscape of advanced glycation end products: a potential link to cardiovascular disease in adults with type 1 diabetes.

Dr Diego Balboa, University of Helsinki

10 000 EUR

Engineered enveloped particles for genome editing of stem cell derived pancreatic islets in vitro.

Diana Toivola, Åbo Akademi University

10 000 EUR

Beta-cell cytoskeletal keratin 18 and its type 1 diabetes associated variant (SNP) in beta-cell function and stress protection.

Dr Tero Jarvinen, Tampere University

10 000 EUR

Accelerated diabetic wound healing by a wound homing peptide.

Dr Amirbabak Sioofy Khojine, Tampere University

10 000 EUR

Efficacy of antiviral therapy: aiming at type 1 diabetes.

2022

  • Norge
  • Norden

Professor Sebastian Barg, Uppsala University

2 000 000 SEK

Paracrine control of islet hormone exocytosis in diabetes.

Professor Tore Bengtsson, Stockholm Universitet

2 000 000 SEK

Novel selectively targeted stimulation of the β2-adrenoceptor for the treatment of type 2 diabetes.

Dr Carolina Hagberg, Karolinska Institute

2 000 000 SEK

Can we prevent adipocyte dysfunction and metabolic disease via metabolic targeting of the adipose tissue?

Dr Benjamin King, Lund Universitet

2 000 000 SEK

Roles of splice isoform CD59-IRIS-1 in beta-cell identity and function.

Dr Olov Andersson, Karolinska Institute

2 000 000 SEK

Stimulating β-cell regeneration as a novel treatment of diabetes.

Dr Ingrid Wernstedt-Asterholm, Universitetet i Gøteborg

2 000 000 SEK

Collagenous Peptides in the Regulation of Adipose Tissue Remodelling.

2021

  • Norge
  • Norden

Professor Marcus Lind, Trollhättan

2 000 000 SEK

A randomized double-blind clinical trial comparing Hypochlorous Acid and Polyhexamethylene biguanide in treating diabetic foot ulcers.

Professor Ulf Ahlgren, Universitetet i Umeå

2 000 000 SEK

High resolution optical 3D imaging to understand human diabetes pathophysiology in a whole organ context.

Professor Nils Wierup, Lunds Universitet

2 000 000 SEK

Studies of T2D disease mechanisms in human islets.

Professor Mia Phillipson, Uppsala Universitet

2 000 000 SEK

The role of immune cell-microbial interactions for long-term islet function and glucose homeostasis.

Professor Per-Ola Carlsson, Uppsala Universitet

2 000 000 SEK

Treat and prevent type 1 diabetes by mesenchymal stromal cells.

Professor Olov Rolandsson, Universitetet i Umeå

1 000 690 SEK

Gastrointestinal adverse effects of metformin in treatment of type 2 diabetes - patients’ perspective and microbiota.

Dr Nicolas Pillon, Karolinska Institute

1 000 000 SEK

Regulation of glucose homeostasis in type 2 diabetes by eicosanoids.

Professor Olga Göransson, Lunds Universitet

1 000 000 SEK

The role of amp-activated protein kinase in the regulation of fatty acid synthesis in adipocytes.

Professor Eva Degerman, Lunds Universitet

316 000 SEK

The inner ear as a target for insulin action-implications for diabetes complications.

2020

  • Norge
  • Norden

Dr Olof Eriksson, Uppsala Universitet

50 000 NOK

GPR44 as a PET marker for measuring beta cell mass in human.

Professor Anders Tengholm, Uppsala Universitet

50 000 NOK

Rap and Ras signalling in insulin secretion.

Professor Patrik Rorsman, Göteborgs Universitet

2 000 000 SEK

Pathophysiologycaemia risk in insulin-treated diabetes patients:more than the sum of the parts? Typ 1 diabetes.

Dr Ingrid Wernstedt Asterholm, Göteborgs Universitet

2 000 000 SEK

Succinate-induced glucose uptake in skeletal muscle - a new therapeutic target for diabetes?

Professor Anders Tengholm, Uppsala Universitet

2 000 000 SEK

Rap and Ras signalling in insulin secretion.

Dr Olof Eriksson, Uppsala Universitet

1 303 200 SEK

GPR44 as a PET marker for measuring beta cell mass in human.

Dr Olof Eriksson, Uppsala University

10 000 EUR

GPR44 as a PET marker for measuring beta cell mass in human

Professor Anders Tengholm, Uppsala University

10 000 EUR

Rap and Ras signalling in insulin secretion

2019

  • Norge
  • Norden

Associate Professor Enming Zhang, Lunds Universitet

2 000 000 SEK

Improvement of diabetic beta cell functions using remotely controlled magnetic nanoparticles.

Professor Mia Phillipson, Uppsala Biomedisinske Senter

2 000 000 SEK

Neonatal infections alter islet maturation and long-term glucose homeostasis.

Professor John Pernow, Karolinska Institute

2 000 000 SEK

The importance of red blood cell dysfunction for cardiovascular complications in diabetes.

Professor Juleen R Zierath, Karolinska Institute

1 000 000 SEK

Reducing sedentary time to improve glucose and lipid metabolism.

Professor Ulf Ahlgren, Umeå Universitet

1 000 000 SEK

The first absolute account of the islet mass distribution in the pancreas of healthy and diabetic individuals.

Dr Alexander Hamilton, CRC Malmö

200 000 SEK

Arginase-2: The potential role of arginine metabolism in beta cell dysfunction.

Dr Marcus Lundberg, Uppsala Universitet

200 000 SEK

Examining acinar tissue of type 1 diabetes pancreata to elucidate the etiology of the disease.

Dr Amaya Lopez, Lunds Universitet

200 000 SEK

Functional validation of T2D dysregulated beta-cell gene regulatory networks.

Cecilia Morgantini, Karolinska Institute

200 000 SEK

Role and relevance of RNA editing of immune cells in obese-induced type 2 diabetes.

Dr Jonathan Cedernaes, Uppsala akademiske sykehus

200 000 SEK

Tissue-targeted circadian interventions for identifying genetic and molecular mechanisms regulating metabolic integrity in healthy and type 2 diabetic humans.

Professor Vesa Olkkonen, University of Helsinki

40 000 EUR

Delineating novel mechanisms of human adipocyte lipid metabolism in typs 2 diabetes and insulin resistance;miR-221-3p as a bait

2018

  • Norge
  • Norden

Mr Fan Rongron, Karolinska Institut

200 000 SEK

Enhancer landscape remodelling during macrophage metaflammatory activation and its involvement in obesity induced metabolic disorder.

Dr Katja Moller-Hackbarth, Karolinska Institute

200 000 SEK

Induced endothelial expression of podocyte specific Retinoic acid receptor responder1 (Rarres1) in Diabetic Kidney Disease (DKD) accelerates renal injury.

Dr John Grunberg, Sahlgrenska, Universitetet i Gøteborg

200 000 SEK

Subcutaneous adipogenesis is a marker of future risk of Type 2 Diabetes – role of endothelial and precursor cell senescence.

Dr Luis Rodrigo Cataldo, Lund Universitet

200 000 SEK

The novel MafA target gene PPP1R1A is modulating the GLP1R-amplifying glucose-stimulated insulin secretion.

Dr Jones Ofori, Lund Universitet

200 000 SEK

Why do type-2 diabetic patients express less synaptotagmin 13 (SYT13) in their islets of Langerhans than healthy individuals?

2017

  • Norge
  • Norden

Professor Nils Wierup, Lunds Universitet

2 000 000 SEK

Discovery and functional validation of regulatory networks in human pancreatic islets to identify targetable disease mechanisms underlying Type 2 diabetes.

Professor Lena Eliasson, Lund Universitet

2 000 000 SEK

Novel therapeutic tools and new biomarkers in diabetes with focus on islet specifik microRNAs.

Professor Per-Ola Carlsson, Uppsala Universitet

2 000 000 SEK

Translational studies of insulinsecreting cells derived from induced pluripotent stem cells.

Dr. Emma Ahlqvist, Lund Universitet

1 981 000 SEK

How many diseases are type 2 diabetes? Confirmation, evaluation and implementation of a new diabetes subclassification.

Dr Bernard Hering, University of Minnesota

850 000 SEK

Refining Immunosuppression to Prevent Rejection of Porcine Islet Xenografts.

Dr. Mototsugu Nagao, Lunds Universitet

200 000 SEK

CD36 as a therapeutic target to improve beta cell function in type 2 diabetes.

Dr. Oskar Skog, Uppsala Universitet

200 000 SEK

Characerization of the diabetic pancreas to unravel the pathogenesis and etiology of type 1 diabetes.

Dr. Andreas Edsfeldt, Lunds Universitet

200 000 SEK

Diabetes associated vascular complications caused by impaired efferocytosis, inflammatory resolution and fibrotic tissue repair.

Dr. Evelina Vågesjö, Uppsala Universitet

200 000 SEK

Mechanisms in skin wound healing in non-diabetic and diabetic conditions and the effect of wound treatment with chemokines.

Dr. Abdul Waheed Khan, Karolinska Institute

200 000 SEK

Role of acetyltransferase GCN5 in endothelial oxidative stress in diabetes.

Dr Bernard Hering, University of Minnesota

167 000 USD

Spring Point Project, its mission is to provide an unlimited source of pig islet cells to accelerate the availability and affordability of islet transplantation to cure diabetes.

2016

  • Norge
  • Norden

Professor Fredrik Bäckhed, Universitetet i Gøteborg

2 000 000 SEK

Determining the microbiota in subjects with prediabetes.

Dr Olof Lagerlöf, Karolinska Institute

1 938 350 SEK

Molecular control over a neuronal circuit that mediates feeding behaviour – and important new target in the fight against diabetes.

Professor Erik Renström, Lunds universitet

1 983 349 SEK

Growth differentiation factor 11 (GDF11) – a fons adolescentia for the pancreatic beta-cell that can delay or prevent onset of type 2 diabetes?

Professor Olle Korsgren, Uppsala universitet

1 800 000 SEK

The role of the duodenal microbiota in the etiopathology of Type 1 Diabetes.

Dr Anna Nordström, Umeå universitet

1 000 000 SEK

6000 steps for better health – a randomised 12-month intervention study.

Professor John Pernow, Karolinska Institute

1 000 000 SEK

The importance of endothelial and red blood cell dysfunction for vascular complications in type 2 diabetes.

Dr Midhat Abdulreda, Diabetes Research Institute Miami University

900 000 SEK

In collaboration with Prof. PO Berggren, Karolinska Institutet: Evaluating vision in the baboon following pancreatic islet transplantation in the eye anterior chamber.

Dr Bernard Hering, University of Minnesota

850 000 SEK

Refining Immunosuppression to Prevent Rejection of Porcine Islet Xenografts.

Professor Eva Degerman, Lunds Universitet

346 000 SEK

Short chain fatty acids; gut metabolites with implications for metabolic health.

Dr Anya Medina Benavente, Lunds Universitet

200 000 SEK

Autophagy in control of beta-cell mass and function in Type 2 Diabetes.

Dr Luis Sarmiento, Lunds Universitet

200 000 SEK

Communication between virus-infected pancreatic beta-cells and the immune system: implication for Type 1 diabetes.

Dr Jennifer Jager, Karolinska Institute

200 000 SEK

Contribution of genes and non-coding RNAs expressed by Kupffer cells in insulin resistance.

Dr Joan Domingo-Espin, Lunds universitet

200 000 SEK

Does Glycation of apoA-I links to higher risk of cardiovascular complications in diabetic patients?

Dr Rashmi Prasad Bokkasa, Lunds universitet

200 000 SEK

Genetic and transcriptomic studies of fetal pancreas to understand fetal programming and development and identification of blood based biomarkers for pancreatic development.

Dr Bernard Hering, University of Minnesota

167 000 USD

Spring Point Project, its mission is to provide an unlimited source of pig islet cells to accelerate the availability and affordability of islet transplantation to cure diabetes.

Mr Nagendra Yaluri, University of Eastern Finland

6 000 EUR

Diabetogenic effects of statins

Dr Jonna Saarimaki-Vire, University of Helsinki

10 000 EUR

Importance of cell-cell interactions and heterogeneity in human pluripotent stem cell-derived islet-like clusters to model diabetes

Mr Shalem Raju Modi, University of Eastern Finland

6 000 EUR

Novel treatments for type 2 diabetes via SIRT1 activation and regulation of insulin sensitivity in muscle and adipose tissues

Dr Aila Ahola, Folkhalsan Institute of Genetics

10 000 EUR

The association between self-management of type 1 diabetes and diabetic complications – Finnish Diabetic Nephropathy (FinnDiane) Study

Dr Riikka Kivela, University of Helsinki

10 000 EUR

Transcription factor Prox1 – a potent regulator of glucose metabolism?

Miss Maria Vahatupa, University of Tampere

10 000 EUR

Vascular homing peptide CAR in pathological retinal angiogenesis and CAR-decorin in ocular fibrosis in mouse

2015

  • Norge
  • Norden

Per-Olof Berggren, Karolinska Institute

2 000 000 SEK

An in vivo approach to understand inositide signalling in the pancreatic beta cell.

Anders Tengholm, Uppsala Universitet

1 000 000 SEK

Betydelsen av budbärarämnet cAMP för reglering av insulin- och glukagonfrisättningen.

Peetra Magnusson, Uppsala Universitet

250 000 SEK

Cellular interactions of mesenchymal stromal cells in type 1 diabetes.

Karin Stenkula, Lunds Universitet

250 000 SEK

Correlation between systemic insulin resistance and bimodal adipose cell response.

Margit Mahlapuu, Universitetet i Gøteborg

925 000 SEK

En ny unik medisinsk behandling av type 2-diabetes basert på hemming av proteinkinaset STK25.

Charlotte Ling, Lunds universitet

1 000 000 SEK

Hvordan påvirker fedme og diabetes type 2 funksjonen til stamcellene i musklene?

Olov Andersson, Karolinska Institute

1 000 000 SEK

Novel strategies for treating diabetes.

Mia Phillipson, Uppsala Universitet

1 002 000 SEK

The role of pancreatic macrophages for development and maturation of islets of Langerhans and long-term metabolic control.

Dariush Mokhtari, Uppsala adademiske sykehus

250 000 SEK

Tissue factor signaling in islets and beta-cells.

Juleen Zierath och Anna Krook, Karolinska Institute

1 000 000 SEK

Träningsintervention vid metabola sjukdomar.

Helena Edlund, Umeå Universitet

2 000 000 SEK

Typ 2 diabetes: en betacellsdegenerativ sjukdom?

Francesco Paneni, Karolinska Institute

250 000 SEK

Understanding redox signalling in diabetic cardiomyopathy: role of AP-1 transcription factor JunD.

Ola Hansson, Lunds universitet

1 000 000 SEK

Vilken påverkan har ärftlighet på muskelegenskaper och metabolsjukdom? - funktionen av RAB3GAP2 och MAOA.

Tero Jarvinen Medical School, University of Tampere

10 000 EUR

Enhanced wound healing in diabetes by wound homing, cell penetrating peptide induced syndecan-4 dependent cell migration

Sanna Lehtonen, University of Helsinki

10 000 EUR

Identification of small molecules that enhance beta cell proliferation and differentiation

Diego Balboa, University of Helsinki

10 000 EUR

In vitro maturation of stem cell derived pancreatic beta cells for diabetes research grant

Maarit Lehti, LIKES Foundation, Jyvaskyla

10 000 EUR

Significance of HDL-C on energy metabolism in type 2 diabetes

Essi Havula, University of Helsinki

10 000 EUR

Transcriptional control of dietary sugar metabolism and homeostasis